• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏中 NHE1 的缺乏:对非酒精性脂肪性肝病的影响。

NHE1 deficiency in liver: implications for non-alcoholic fatty liver disease.

机构信息

Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati College of Medicine, United States.

Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati College of Medicine, United States.

出版信息

Biochem Biophys Res Commun. 2014 Jul 25;450(2):1027-31. doi: 10.1016/j.bbrc.2014.06.095. Epub 2014 Jun 26.

DOI:10.1016/j.bbrc.2014.06.095
PMID:24976401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4111981/
Abstract

Non-alcoholic fatty liver disease NAFLD is closely associated with the dysregulation of lipid homeostasis. Diet-induced hepatic steatosis, which can initiate NAFLD progression, has been shown to be dramatically reduced in mice lacking the electroneutral Na(+)/H(+) exchanger NHE1 (Slc9a1). In this study, we investigated if NHE1 deficiency had effects in liver that could contribute to the apparent protection against aberrant lipid accumulation. RT-PCR and immunoblot analyses of wild-type and NHE1-null livers revealed an expression profile that strongly suggested attenuation of both de novo lipogenesis and hepatic stellate cell activation, which is implicated in liver fibrosis. This included upregulation of the farnesoid X receptor FXR, peroxisome proliferator-activated receptor PPARγ, its co-activator PGC1α, and sestrin 2, an antioxidant protein involved in hepatic metabolic homeostasis. Furthermore, expression levels of the pro-lipogenic liver X receptor LXRα, and acetyl CoA carboxylases 1 and 2 were downregulated. These changes were associated with evidence of reduced cellular stress, which persisted even upon exposure to a high-fat diet, and the better preservation of insulin signaling, as evidenced by protein kinase B/Akt phosphorylation (Ser473). These results indicate that NHE1 deficiency may protect against NAFLD pathogenesis, which is significant given the availability of highly specific NHE1 inhibitors.

摘要

非酒精性脂肪性肝病 (NAFLD) 与脂质动态平衡失调密切相关。饮食诱导的肝脂肪变性可引发 NAFLD 进展,研究表明缺乏电中性 Na(+)/H(+)交换蛋白 NHE1 (Slc9a1) 的小鼠中肝脂肪变性显著减少。在这项研究中,我们研究了 NHE1 缺乏是否会对肝脏产生影响,从而有助于对异常脂质积累的明显保护作用。对野生型和 NHE1 敲除型肝脏的 RT-PCR 和免疫印迹分析显示,表达谱强烈表明从头合成脂质和肝星状细胞激活均受到抑制,这与肝纤维化有关。这包括法尼醇 X 受体 FXR、过氧化物酶体增殖物激活受体 PPARγ、其共激活因子 PGC1α 和参与肝代谢稳态的抗氧化蛋白 sestrin 2 的上调。此外,促脂性肝 X 受体 LXRα 和乙酰辅酶 A 羧化酶 1 和 2 的表达水平下调。这些变化与细胞应激减少有关,即使在高脂肪饮食暴露下,这种应激也持续存在,胰岛素信号的保存更好,如蛋白激酶 B/Akt 磷酸化 (Ser473) 所示。这些结果表明,NHE1 缺乏可能会预防 NAFLD 发病机制,鉴于存在高度特异性的 NHE1 抑制剂,这一点意义重大。

相似文献

1
NHE1 deficiency in liver: implications for non-alcoholic fatty liver disease.肝脏中 NHE1 的缺乏:对非酒精性脂肪性肝病的影响。
Biochem Biophys Res Commun. 2014 Jul 25;450(2):1027-31. doi: 10.1016/j.bbrc.2014.06.095. Epub 2014 Jun 26.
2
Loss of NHE1 activity leads to reduced oxidative stress in heart and mitigates high-fat diet-induced myocardial stress.NHE1 活性的丧失可减少心脏的氧化应激,并减轻高脂肪饮食诱导的心肌应激。
J Mol Cell Cardiol. 2013 Dec;65:33-42. doi: 10.1016/j.yjmcc.2013.09.013. Epub 2013 Sep 29.
3
Free radical biology for medicine: learning from nonalcoholic fatty liver disease.医学中的自由基生物学:从非酒精性脂肪性肝病中学习。
Free Radic Biol Med. 2013 Dec;65:952-968. doi: 10.1016/j.freeradbiomed.2013.08.174. Epub 2013 Aug 29.
4
Modulation of xenobiotic nuclear receptors in high-fat diet induced non-alcoholic fatty liver disease.高脂饮食诱导的非酒精性脂肪性肝病中外源物核受体的调控。
Toxicology. 2018 Dec 1;410:199-213. doi: 10.1016/j.tox.2018.08.007. Epub 2018 Aug 16.
5
Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.下调 microRNA-130b-5p 可预防非酒精性脂肪性肝病小鼠模型中的脂质积累和胰岛素抵抗。
Am J Physiol Endocrinol Metab. 2020 Jul 1;319(1):E34-E42. doi: 10.1152/ajpendo.00528.2019. Epub 2020 Mar 31.
6
Fructose as a key player in the development of fatty liver disease.果糖在脂肪性肝病的发生发展中扮演关键角色。
World J Gastroenterol. 2013 Feb 28;19(8):1166-72. doi: 10.3748/wjg.v19.i8.1166.
7
Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.限制蛋氨酸摄入可防止瘦素缺乏型肥胖小鼠的肝脂肪变性进展。
Metabolism. 2013 Nov;62(11):1651-61. doi: 10.1016/j.metabol.2013.06.012. Epub 2013 Aug 5.
8
NHE1 regulation in NAFLD in vitro contributes to hepatocyte injury and HSC crosstalk.体外研究表明 NHE1 在非酒精性脂肪性肝病中的调节作用导致肝细胞损伤和肝星状细胞的相互作用。
J Endocrinol. 2024 Oct 8;263(2). doi: 10.1530/JOE-24-0099. Print 2024 Nov 1.
9
Nhe1 is a luminal Na+/H+ exchanger in mouse choroid plexus and is targeted to the basolateral membrane in Ncbe/Nbcn2-null mice.Nhe1是小鼠脉络丛中的一种管腔Na+/H+交换体,在Ncbe/Nbcn2基因敲除小鼠中定位于基底外侧膜。
Am J Physiol Cell Physiol. 2009 Jun;296(6):C1291-300. doi: 10.1152/ajpcell.00062.2009. Epub 2009 Apr 15.
10
Stimulation of astrocyte Na+/H+ exchange activity in response to in vitro ischemia depends in part on activation of ERK1/2.体外缺血反应中星形胶质细胞钠/氢交换活性的刺激部分取决于细胞外信号调节激酶1/2(ERK1/2)的激活。
Am J Physiol Cell Physiol. 2005 Oct;289(4):C934-45. doi: 10.1152/ajpcell.00092.2005. Epub 2005 May 18.

引用本文的文献

1
The Role of Solute Carrier Family Transporters in Hepatic Steatosis and Hepatic Fibrosis.溶质载体家族转运蛋白在肝脂肪变性和肝纤维化中的作用。
J Clin Transl Hepatol. 2025 Mar 28;13(3):233-252. doi: 10.14218/JCTH.2024.00348. Epub 2025 Jan 22.
2
GCKIII kinases control hepatocellular lipid homeostasis via shared mode of action.GCKIII 激酶通过共享作用模式控制肝细胞脂质稳态。
J Lipid Res. 2024 Nov;65(11):100669. doi: 10.1016/j.jlr.2024.100669. Epub 2024 Oct 10.
3
The Expression of NHE8 in Liver and Its Role in Carbon Tetrachloride-Induced Liver Injury.NHE8在肝脏中的表达及其在四氯化碳诱导的肝损伤中的作用
Gastro Hep Adv. 2023;2(2):199-208. doi: 10.1016/j.gastha.2022.09.008. Epub 2022 Sep 22.
4
Alleviation of liver cirrhosis and associated portal-hypertension by Astragalus species in relation to their UPLC-MS/MS metabolic profiles: a mechanistic study.黄芪属物种通过 UPLC-MS/MS 代谢谱减轻肝硬化及相关门静脉高压症:一项机制研究。
Sci Rep. 2022 Jul 13;12(1):11884. doi: 10.1038/s41598-022-15958-1.
5
Target Sestrin2 to Rescue the Damaged Organ: Mechanistic Insight into Its Function.靶向 Sestrin2 以拯救受损器官:对其功能的机制见解。
Oxid Med Cell Longev. 2021 Nov 2;2021:8790369. doi: 10.1155/2021/8790369. eCollection 2021.
6
Dynamic Na/H exchanger 1 (NHE1) - calmodulin complexes of varying stoichiometry and structure regulate Ca-dependent NHE1 activation.动态钠离子/氢离子交换器 1(NHE1)-不同计量和结构的钙调蛋白复合物调节钙离子依赖性 NHE1 激活。
Elife. 2021 Mar 3;10:e60889. doi: 10.7554/eLife.60889.
7
Pathophysiology of hepatic Na/H exchange (Review).肝脏钠/氢交换的病理生理学(综述)
Exp Ther Med. 2020 Aug;20(2):1220-1229. doi: 10.3892/etm.2020.8888. Epub 2020 Jun 12.
8
NBCe1 Na-HCO3 cotransporter ablation causes reduced apoptosis following cardiac ischemia-reperfusion injury .NBCe1钠-碳酸氢根共转运体缺失导致心脏缺血再灌注损伤后细胞凋亡减少。
World J Cardiol. 2018 Sep 26;10(9):97-109. doi: 10.4330/wjc.v10.i9.97.
9
SLC9 Gene Family: Function, Expression, and Regulation.SLC9 基因家族:功能、表达与调控。
Compr Physiol. 2018 Mar 26;8(2):555-583. doi: 10.1002/cphy.c170027.

本文引用的文献

1
ER stress and hepatic lipid metabolism.内质网应激与肝脏脂质代谢。
Front Genet. 2014 May 9;5:112. doi: 10.3389/fgene.2014.00112. eCollection 2014.
2
Insulin-sensitizing effect of LXR agonist T0901317 in high-fat fed rats is associated with restored muscle GLUT4 expression and insulin-stimulated AS160 phosphorylation.肝脏X受体激动剂T0901317对高脂喂养大鼠的胰岛素增敏作用与肌肉中葡萄糖转运蛋白4表达的恢复及胰岛素刺激的AS160磷酸化有关。
Cell Physiol Biochem. 2014;33(4):1047-57. doi: 10.1159/000358675. Epub 2014 Apr 4.
3
FXR is a molecular target for the effects of vertical sleeve gastrectomy.FXR 是垂直袖状胃切除术作用的分子靶点。
Nature. 2014 May 8;509(7499):183-8. doi: 10.1038/nature13135. Epub 2014 Mar 26.
4
Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH).多种打击,包括氧化应激,作为非酒精性脂肪性肝炎(NASH)的发病机制和治疗靶点。
Int J Mol Sci. 2013 Oct 15;14(10):20704-28. doi: 10.3390/ijms141020704.
5
Loss of NHE1 activity leads to reduced oxidative stress in heart and mitigates high-fat diet-induced myocardial stress.NHE1 活性的丧失可减少心脏的氧化应激,并减轻高脂肪饮食诱导的心肌应激。
J Mol Cell Cardiol. 2013 Dec;65:33-42. doi: 10.1016/j.yjmcc.2013.09.013. Epub 2013 Sep 29.
6
Sestrins orchestrate cellular metabolism to attenuate aging.Sestrins 调控细胞代谢以延缓衰老。
Cell Metab. 2013 Dec 3;18(6):792-801. doi: 10.1016/j.cmet.2013.08.018. Epub 2013 Sep 19.
7
Mitochondrial NHE1: a newly identified target to prevent heart disease.线粒体 NHE1:预防心脏病的新靶点。
Front Physiol. 2013 Jun 28;4:152. doi: 10.3389/fphys.2013.00152. Print 2013.
8
Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease.法尼醇 X 受体激动剂奥贝胆酸治疗 2 型糖尿病合并非酒精性脂肪性肝病患者的疗效和安全性。
Gastroenterology. 2013 Sep;145(3):574-82.e1. doi: 10.1053/j.gastro.2013.05.042. Epub 2013 May 30.
9
The liver X receptor: a master regulator of the gut-liver axis and a target for non alcoholic fatty liver disease.肝 X 受体:肠道-肝脏轴的主调控因子及非酒精性脂肪性肝病的治疗靶点。
Biochem Pharmacol. 2013 Jul 1;86(1):96-105. doi: 10.1016/j.bcp.2013.03.016. Epub 2013 Mar 28.
10
Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance.合成 FXR 激动剂 GW4064 可预防饮食诱导的肝脂肪变性和胰岛素抵抗。
Pharm Res. 2013 May;30(5):1447-57. doi: 10.1007/s11095-013-0986-7. Epub 2013 Feb 1.